A new congressionally mandated report examines how opioid and benzodiazepine prescribing between 2007 and 2019 impacted all-cause mortality among veterans treated at the VHA.

Researchers at University of the Pacific in Stockton have developed a long-acting opioid overdose-reversal drug-delivery system that could save lives.

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries.

Almost 1,200 people in Kern County have died from fentanyl overdoses since 2018, including 171 in 2024 and an all-time high of 294 the year before, according to updated numbers from the Kern County ...

The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.

Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

Vertex Pharmaceuticals’ non-opioid pain medication is up for FDA approval this week. Other drugmakers have found safer ...

in which dose calculation errors are the most common type of medication errors. It’s all too easy to see how calculations can be complicated in an emergency response. Put yourself in a cardiac ...

The usual Strattera (atomoxetine) dosage for ADHD is 80 milligrams per day. Specific dosages may vary depending on factors like your age and other medications you may be taking. It’s important ...

Purdue Pharma’s Sackler family owners are offering to increase their financial contribution to a bankruptcy settlement of opioid lawsuits while accepting some exposure to future litigation ...

Jan 13 (Reuters) - The Sackler family owners of Purdue Pharma are offering to increase their financial contribution to a bankruptcy settlement of opioid lawsuits, while agreeing to some exposure ...